Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Clinical trial NCT00625456 · COMPLETED

Trial details

NCT number: NCT00625456
Sponsor: Jennerex Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Lung Cancer Renal Cell Carcinoma Squamous Cell Carcinoma of the Head and Neck

Start date: 2008-06-01
Primary completion: 2010-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.